AlphaYouSL
Insider selling
Shao-Lee Lin sold $1.6M of Cue Biopharma, Inc. (CUE) stock
Shao-Lee Lin, Chief Executive Officer of Cue Biopharma, Inc. (CUE), sold 58,258 shares of CUE stock worth $1.6M, per an SEC Form 4 filed Aug 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 12, 2026, 3 days before it was made public.
CUE has moved -7.1% since the trade date, from $30.42 to $28.27 (Sep 21, 2026 close).
- Traded
- Aug 12, 2026
- Disclosed
- Aug 15, 2026
- Filing delay
- 3 days
- Price since
- -7.1%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More CUE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.